Joleen Hubbard, MD, Highlights The “Exciting Space” Of Metastatic CRC
New studies and treatment options prove to be effective in treating metastatic CRC, notes Joleen Hubbard, MD.
Circulating Tumor DNA and MRD Assessment in Colorectal Cancer
The expert panel offers closing thoughts on MRD assessment and how ctDNA has been incorporated into clinical practice in the treatment of colorectal cancer.
Effect of MRD on Adjuvant Therapy and Monitoring Strategies in CRC
Specialists on colorectal cancer discuss the effect of MRD on monitoring strategies and adjuvant therapy decisions for patients with colorectal cancer.
CRC: Clinical Trial Landscape for MRD-Based Early Intervention
An overview colorectal cancer clinical trials studying early intervention based on MRD positivity.
MD Anderson INTERCEPT Program: ctDNA and Recurrence in CRC
Aparna Parikh, MD, MS, talks about the MD Anderson INTERCEPT program, which is studying the relationship between ctDNA and recurrence in colorectal cancer.
CIRCULATE-Japan: Using ctDNA to Guide Adjuvant Therapy in CRC
Daniel H. Ahn, DO, discusses the CIRCULATE-Japan trial, which is studying how ctDNA can be used to guide adjuvant therapy in colorectal cancer.
Colorectal Cancer: ctDNA vs cfDNA for Assessing MRD
The panel compares cfDNA with ctDNA for assessing MRD, and outlines when ctDNA testing is ordered and how it’s collected.
CEA vs ctDNA for Monitoring Patients with Colorectal Cancer
Joleen Hubbard, MD, compares CEA with ctDNA for monitoring patients with colorectal cancer.
Patient Monitoring after Adjuvant Chemotherapy in Colorectal Cancer
Medical oncologists who specialize in gastrointestinal cancers offer clinical insights on monitoring patients following treatment with adjuvant chemotherapy.
Colorectal Cancer Treatment Considerations Following IDEA Collaboration Analysis
A comprehensive discussion on treatment decision-making for patients with colorectal cancer following the IDEA collaboration analysis.
Effect of MRD Positivity on Treatment Decisions in Colorectal Cancer
The expert panel discusses how MRD positivity affects treatment decisions for patients with colorectal cancer.
Patient Profile: A 55-Year-Old With Colon Cancer
Experts on colorectal cancer present a patient case, offer their initial impressions, and discuss disease staging.
Circling Back: The Effects of Emerging Molecular Understanding on Treatment Decisions in Colorectal Cancer
Points made in commentaries on “Colorectal Cancer: How Emerging Molecular Understanding Affects Treatment Decisions” are addressed by authors Hubbard and Grothey.
Colorectal Cancer: How Emerging Molecular Understanding Affects Treatment Decisions
In this review we discuss the current treatment options in metastatic colon cancer, with a special focus on biologic agents and how molecular understanding guides treatment decisions.
